Atlas Trials

A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study

Clinical trial NCT07751497 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07751497
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Vestibular Migraine
Start date
2026-12-01
Primary completion
2027-12-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.